"This... this technology, someone actually researched and developed it?"
"I can hardly believe my eyes. Which professor today has achieved such academic success?"
"Could this be Professor Eric's research? No, that doesn't make sense either. Aren't Nobel Prize nominees supposed to be nominated by themselves?"
The group was still engaged in a heated discussion.
"Everyone, be quiet, be quiet, listen to me first."
"I think after reading the paper, everyone understands why I urgently convened this meeting."
"Now, I would like everyone to have a serious discussion on whether we should accept the nomination for this paper."
"If everyone accepts this, I believe that the winner of this year's Nobel Prize in Medicine is no longer up for discussion."
Professor William said these words.
Many people present nodded silently.
Half an hour later.
Everyone made their decision.
Professor William then looked around at everyone present, and raised his voice:
"For now, we will still use the show of hands method to vote."
"Raise your hand if you agree to include this paper in the Nobel Prize nomination!"
"Whoosh!"
As Professor William finished speaking.
Everyone in the meeting room seemed to have planned it in advance.
They all raised their right hands.
"Wh-what!"
"It passed unanimously!"
"Such a result is absolutely unprecedented since the establishment of the Nobel Prize in Medicine!"
"Slap, slap, slap."
Everyone was engaged in a heated discussion, and applause was deafening.
They understood that they had not only witnessed history.
Moreover, the attitude of each person in raising their hand to vote also means...
The Nobel Prize in Medicine for this year has already been announced ahead of schedule.
That's Su Chen's paper on "Drug Reverse Reconstruction R&D Technology"!
At the same time as the Nobel Prize selection process.
Recombinant Human is in continuous production.
At present, the production capacity of Fucogene is no longer solely being carried out by Runze Biotechnology.
Zhou Ting and Su Chen have already followed the cooperation agreements they signed with several pharmaceutical companies in Jiangcheng City.
The manufacturing is outsourced to other companies.
In a short time, more Recombinant Human was put into the market.
The entire country's hospitals and pharmacies were quickly taken over by Fucojian.
The net profit of pharmaceuticals also rose directly from the initial 230 million to 1 billion!
Many people have even started overseas purchasing agents.
However, these overseas purchasing agents don't bring goods to China, but rather to other countries.
As Regenerist's reputation soared.
Even some social media platforms abroad.
Everyone started reporting on this.
On TikTok, the short video interviewing Su Chen quickly went viral.
The youngest professor in China's history has been revealed; his true identity is actually an undergraduate student who hasn't even graduated yet!
[An ancient and mysterious land creates another miracle: the miraculous medicine Fukejian sweeps the globe!]
[Tens of thousands of Americans have signed a petition, urgently requesting the export of this drug to overseas markets!]
The constant generation of trending search terms instantly made Su Chen's fame and his drug a hot topic of conversation in the United States.
The price of a single box of Recombinant Human Pharmacy Solution that was resold by daigou (personal shoppers) has been inflated to over $500!
Even so, it's still available but unsellable.
As the event gains more and more attention.
Even General Douglas MacArthur, a renowned commentator based in the United States, couldn't help but comment after reading it.
"It's not that we can't afford the exorbitantly priced medicine of $10,000, but rather that the $500 Recombinant Human is more cost-effective."
And in the west of China.
India, a country world-renowned for its generic drugs.
Major generic drug companies are working overtime to research the formula for Fucojian.
This time, however, their generic drug technology was based on the drug that Su Chen was researching.
We encountered difficulties.
The development of this drug employed reverse reconstruction technology.
It is different from the current mainstream drug development technologies.
The paper on this technology was only recently published, so it is not yet widely known by major pharmaceutical companies around the world.
In addition, there's Su Chen's astonishing pharmaceutical compound modification technology.
For a time, a technological gap was created in the entire field of drug development on Earth.
It's like asking you to use a computer from 20 years ago to run software from 20 years later.
In terms of RAM alone, it simply can't handle it.
In addition, Su Chen's drug is priced very low.
This leaves Indian generic drugs with no advantage over the original Recombinant Human in terms of either research and development costs or clinical efficacy.
Finally, after a collective discussion among high-level officials in the Indian medical field.
They chose to abandon the development of generic versions of Fucogene.
at the same time.
Within China.
Not only the medical department, but even the customs department has noticed the special nature of this drug.
They contacted Su Chen, Zhou Ting, and others overnight.
This illustrates the current popularity of Recombinant Human (Recombinant Human) products.
After discussion, a solution was quickly developed.
Firstly, customs has strengthened export controls on Recombinant Human Health products in order to prevent a large amount of pharmaceutical resources from flowing to overseas countries.
Secondly, Su Chen and his team urgently signed cooperation agreements with several pharmaceutical companies to develop a production line specifically for exporting pharmaceuticals overseas.
After investigation, Su Chen and his team set the export price of Regenerist at $300 per box.
This chapter is not finished yet. Please click on the next page to continue reading the exciting content!
Continue read on readnovelmtl.com
